Why are Central and Eastern Europe the hottest locations for clinical trials? Join Vlad Bogin, MD, FACP, CEO Cromos Pharma at #OCTEasternEurope15 June 2021 to find out more.  At Cromos Pharma we have in-depth knowledge of these regions and the expertise to manage your clinical trial from start to end. Email bd@cromospharma.com to set up a meeting to discuss your needs.

After a year-long delay due to the COVID-19 pandemic, the EU Medical Devices Regulation (EU MDR) is set to come into effect on May 26th 2021. Regulation 2017/746 on In-Vitro Diagnostic Devices (IVDR) will come into effect May 2022 after a five year transition period. These Regulations have a staggered transitional period with some aspects becoming legally binding after 6 months of

With its rapid regulatory approval process, significant naïve populations in a range of therapeutic areas, skilled medical personnel and a conducive economic environment for doing business, Georgia is regarded as a hidden gem for those interested in initiating novel studies and rescue trials. Cromos Pharma in Georgia Cromos Pharma began managing clinical research in Georgia